Transcatheter Treatment Options for Functional Mitral Regurgitation: Which Device for Which Patients?

Mitral regurgitation is the most common valvular disease in the developed world, with approximately 24.2 million people being affected worldwide and a higher prevalence in older age groups. Surgical correction of degenerative mitral regurgitation is the standard of care and can restore cardiac function and provide a lasting result, especially when the mitral valve can be repaired. Secondary mitral regurgitation, or functional mitral regurgitation (FMR), describes atrial or ventricular factors leading to poor coaptation of an otherwise non-diseased valve. For FMR, traditional surgery has not produced the same level of benefit. Transcatheter mitral repair and replacement techniques that mimic surgical correction are under investigation. Transcatheter edge-to-edge repair is the only approved catheter-based therapy for FMR in the US. Here, the transcatheter treatment options for FMR are reviewed.

Informations de copyright

Copyright © The Author(s), 2024. Published by Radcliffe Group Ltd.

Déclaration de conflit d'intérêts

Disclosure: AG is a consultant for Edwards Lifesciences. KJG is a consultant for Abbott, Boston Scientific, Medtronic, Edwards Lifesciences and 4C Medical. CMD is a paid consultant for Edwards Lifesciences, Medtronic, ReCor Medical and Shockwave Medical. All other authors have no conflicts of interest to declare.